FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,250,000 shares of Aspen Neuroscience Inc. common stock as of October 30, 2026.

Key Highlights

  • Triggering event date: The filing reports ownership as of October 30, 2026.
  • Shares reported: FMR LLC and Abigail P. Johnson each report beneficial ownership of 3,250,000 shares of Aspen Neuroscience Inc. common stock.
  • Percent of class: The 3,250,000 shares represent 11.2% of the outstanding common stock, according to the filing.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson report sole dispositive power over all 3,250,000 shares, with no shared dispositive power.
  • Voting power: FMR LLC reports sole voting power over 3,250,000 shares; Abigail P. Johnson reports sole voting power of 0 shares.
  • Other beneficial interests: The filing states that one or more other persons have the right to receive or direct receipt of dividends or sale proceeds, but no single other person holds more than 5% of the total outstanding common stock.

FMR LLC Discloses Ownership Position in Aspen Neuroscience as of October 30, 2026

FMR LLC, organized in Delaware and headquartered at 245 Summer Street, Boston, Massachusetts 02210, filed a Schedule 13G disclosing a beneficial ownership position in Aspen Neuroscience Inc. (NASDAQ:ASPE), a company whose principal executive offices are located at 10835 Road to the Cure, Suite 100, San Diego, CA 92121. The filing covers common stock with CUSIP number 044933109. The event triggering the filing occurred on October 30, 2026, and the statement was signed on November 5, 2026 by Stephanie J. Brown, acting under a power of attorney on behalf of both FMR LLC and Abigail P. Johnson.

According to the filing, FMR LLC is classified as a parent holding company or control person under Rule 13d-1(b)(1)(ii)(G), and Abigail P. Johnson is classified as an individual reporting person. FMR LLC reports sole voting power over 3,250,000 shares, while Abigail P. Johnson reports sole voting power of 0 shares. Both report sole dispositive power over 3,250,000 shares, and neither reports any shared voting or dispositive power. The aggregate beneficial ownership reported by each person is 3,250,000 shares, equaling 11.2% of the class.

The filing certifies, as required by Schedule 13G, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing references Exhibit 99 for identification and classification of the subsidiary through which the position was acquired, as required when a parent holding company files under Rule 13d-1(b)(ii)(G).

What Was Disclosed

FMR LLC and Abigail P. Johnson filed a Schedule 13G reporting combined beneficial ownership of 3,250,000 shares, or 11.2%, of Aspen Neuroscience Inc. common stock as of October 30, 2026, with sole dispositive power and no shared voting or dispositive power reported.